Home/Filings/4/0001209191-18-011629
4//SEC Filing

YUSPEH ALAN R 4

Accession 0001209191-18-011629

CIK 0000860730other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 8:08 PM ET

Size

14.8 KB

Accession

0001209191-18-011629

Insider Transaction Report

Form 4
Period: 2018-02-16
YUSPEH ALAN R
SVP & Chief Ethics Officer
Transactions
  • Tax Payment

    Common Stock

    2018-02-16$101.00/sh6,497$656,19728,534 total
  • Exercise/Conversion

    Stock Appreciation Right

    2018-02-165,5000 total
    Exercise: $37.18Exp: 2023-02-06Common Stock (5,500 underlying)
  • Exercise/Conversion

    Common Stock

    2018-02-16$37.18/sh+12,375$460,10335,031 total
  • Exercise/Conversion

    Stock Appreciation Right

    2018-02-166,8750 total
    Exercise: $37.18Exp: 2023-02-06Common Stock (6,875 underlying)
Footnotes (2)
  • [F1]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
  • [F2]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001216859

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 8:08 PM ET
Size
14.8 KB